Sei Investments Co. Sells 128,889 Shares of Stevanato Group S.p.A. (NYSE:STVN)

Sei Investments Co. trimmed its stake in shares of Stevanato Group S.p.A. (NYSE:STVN - Free Report) by 39.3% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 199,474 shares of the company's stock after selling 128,889 shares during the quarter. Sei Investments Co. owned approximately 0.07% of Stevanato Group worth $4,346,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also added to or reduced their stakes in STVN. M&T Bank Corp acquired a new position in shares of Stevanato Group during the fourth quarter worth $572,000. Mutual of America Capital Management LLC bought a new stake in Stevanato Group during the 4th quarter worth $13,848,000. Wellington Management Group LLP increased its holdings in Stevanato Group by 4.5% in the 3rd quarter. Wellington Management Group LLP now owns 2,693,588 shares of the company's stock worth $53,872,000 after purchasing an additional 115,050 shares in the last quarter. Jennison Associates LLC bought a new position in Stevanato Group in the fourth quarter valued at about $20,239,000. Finally, Glenmede Trust Co. NA boosted its stake in shares of Stevanato Group by 12.7% during the third quarter. Glenmede Trust Co. NA now owns 35,941 shares of the company's stock valued at $719,000 after purchasing an additional 4,050 shares in the last quarter.

Wall Street Analysts Forecast Growth

STVN has been the subject of several recent research reports. UBS Group lowered their price objective on Stevanato Group from $24.00 to $23.50 and set a "neutral" rating for the company in a research note on Friday, March 7th. Bank of America upped their price target on shares of Stevanato Group from $24.00 to $26.00 and gave the company a "buy" rating in a research report on Friday, December 13th. Wolfe Research began coverage on shares of Stevanato Group in a report on Friday, December 13th. They set an "outperform" rating and a $28.00 price target on the stock. Finally, William Blair restated an "outperform" rating on shares of Stevanato Group in a report on Friday, March 7th. Two analysts have rated the stock with a hold rating and five have issued a buy rating to the stock. According to MarketBeat, the stock has a consensus rating of "Moderate Buy" and an average target price of €25.70 ($27.93).

Stevanato Group Trading Up 1.1 %

Shares of NYSE STVN traded up €0.21 ($0.23) during midday trading on Monday, reaching €19.23 ($20.90). The stock had a trading volume of 535,800 shares, compared to its average volume of 355,609. Stevanato Group S.p.A. has a twelve month low of €16.56 ($18.00) and a twelve month high of €30.10 ($32.72). The company has a debt-to-equity ratio of 0.22, a quick ratio of 1.21 and a current ratio of 1.81. The company's 50 day moving average price is €20.70 and its 200 day moving average price is €20.61. The firm has a market cap of $5.82 billion, a price-to-earnings ratio of 40.91, a price-to-earnings-growth ratio of 7.18 and a beta of 0.52.

Stevanato Group (NYSE:STVN - Get Free Report) last released its earnings results on Thursday, March 6th. The company reported €0.20 ($0.22) earnings per share (EPS) for the quarter, meeting the consensus estimate of €0.20 ($0.22). Stevanato Group had a net margin of 10.47% and a return on equity of 9.86%. The business had revenue of €352.68 million for the quarter, compared to analyst estimates of €346.26 million. As a group, sell-side analysts expect that Stevanato Group S.p.A. will post 0.5 EPS for the current year.

Stevanato Group Company Profile

Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for bio-pharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific. The company operates in two segments, Biopharmaceutical and Diagnostic Solutions; and Engineering.